Microdetermination of propofol in plasma by a rapid and sensitive liquid chromatographic method |
| |
Affiliation: | 1. University of Natural Sciences and Humanities, Faculty of Exact and Natural Sciences, Institute of Biological Sciences, Prusa 14, 08-110 Siedlce, Poland;2. Institute of Ichthyobiology and Aquaculture in Gołysz, Polish Academy of Sciences, Kalinowa 2, 43-520 Chybie, Poland;1. Department of Fisheries and Watershed Management, Faculty of Renewable Natural Resources, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana;2. Technical University of Denmark, DTU Aqua, Section for Aquaculture, The North Sea Research Centre, PO Box 101, DK-9850 Hirtshals, Denmark |
| |
Abstract: | A direct and sensitive liquid chromatographic method for the determination of propofol in 50 μl of plasma is described. The separation of the drug and internal standard (methyldopa) was achieved using a 4 μm particle size C18 cartridge (10 cm × 8 mm i.d.) in conjunction with a radial compression system and a C18 precolumn module. The mobile phase consisted of 0.01 M sodium acetate solution (adjusted to pH 3 with acetic acid)-acetonitrile-methanol (37:47.25:15.75, v/v/v) at a flow rate of 2 ml min−1. The compounds were detected in the effluent spectrofluorimetrically with excitation and emission wavelengths of 276 and 310 nm, respectively. After the internal standard had been added, the sample was diluted with 50 μl of hydrochloric acid and centrifuged prior to injection into the chromatograph. The peaks of both propofol and internal standard under these conditions were sharp and symmetrical, and the retention times were 8.2 and 5.15 min, respectively. The peak-height ratio (drug/internal standard) varied linearly (r > 0.9959) with concentration in the ranges 0.002–0.1 and 0.1–10 μg ml−1 and the relative standard deviation was consistently < 5.6%. There was no interference in the assay from the endogenous substance or other concomitantly used drug. This method is currently being used for monitoring propofol in intensive care patients and investigating its pharmacokinetics. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|